Genesis Molecular AI launches Ruby potency model, up to 1000x faster, open-sources training data

edunov · x · 2026-11-21

Genesis Molecular AI unveiled Ruby, an AI model for predicting drug candidate potency, building on last year's 3D binding model Pearl without needing full 3D structures — hence its speed. With pharma partner Incyte, Ruby showed a step-change on real drug programs and runs 40x–1000x+ faster per compound at its fastest setting, leading all published models found on public benchmarks including free-energy methods. Genesis is also open-sourcing GenesisPotency-2026, part of its audited training data, free for academic and commercial use.

Related event: Genesis Releases Open-Source Drug Potency Model Ruby(2 posts)→

Original post →

More from Research

Research channel →